Biosimilar Nivestym Gets FDA Approval  Monthly Prescribing Reference

The Food and Drug Administration (FDA) has approved Nivestym (filgrastim-aafi; Pfizer), a biosimilar to Neupogen (filgrastim; Amgen). The approval was based …

X